Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation [Phase 3]
Phase 3 trial of the nMARQ Pulmonary Vein Isolation System for paroxysmal atrial fibrillation was terminated, with results posted in Decembe…
-
CLINICAL_TRIALS trial_result · 2018-12-07Clinical Trial Update: Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery [Phase 1, Phase 2]
A Phase 1/2 clinical trial tested temporary autonomic blockade to prevent atrial fibrillation after cardiac surgery. The study is completed …
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF) [Phase 1]
Phase 1 trial updating safety, pharmacokinetics, and efficacy of OPC-108459 given as a single IV dose in patients with atrial fibrillation; …
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: FIRE AND ICE: Comparative Study of Two Ablation Procedures in Patients With Atrial Fibrillation [NA]
The FIRE AND ICE trial comparing two ablation procedures in symptomatic paroxysmal atrial fibrillation has completed and posted results in 2…
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: Anticoagulants Comparative Benefit-risk Ratio in Real Life
A completed clinical trial comparing real-life benefit-risk of anticoagulants in atrial fibrillation; results posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-11-02FDA Approved: SOTALOL HYDROCHLORIDE AF — Original Application (UNICHEM PHARMACEUTICALS (USA), INC.)
FDA approved Sotalol Hydrochloride AF tablets from Unichem Pharmaceuticals (USA), Inc. as an original application generic product for treati…
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation [Phase 4]
Phase 4 clinical trial update evaluating smartphone use to improve adherence to rivaroxaban in atrial fibrillation.
-
CLINICAL_TRIALS research · 2018-10-25Clinical Trial Update: Impact of an Atrial Fibrillation Decision Support Tool (AFDST) on Thromboprophylaxis for Atrial Fibrillation [NA]
A completed clinical trial evaluating the impact of an atrial fibrillation decision support tool on thromboprophylaxis decisions in atrial f…
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: Control Versus Liberal Cardiac Frequency in Patients in Sepse With Atrial Fibrillation of High Ventricular Response [Phase 3]
Phase 3 clinical trial comparing control versus liberal heart rate strategies in septic patients with atrial fibrillation and high ventricul…
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation [Phase 4]
A Phase 4 trial evaluating the use of protamine to reverse heparin during/after catheter ablation for atrial fibrillation has completed with…
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Spironolactone in Atrial Fibrillation [Phase 4]
Phase 4 clinical trial update for spironolactone in atrial fibrillation is reported, status unknown.
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery [Phase 4]
Phase 4 clinical trial evaluating fish oil to reduce atrial fibrillation after cardiac surgery; study completed with results posted in 2018.
-
FDA approval · 2018-10-09FDA Approved: DOFETILIDE — Original Application (NorthStar RxLLC)
FDA approves NorthStar RxLLC's generic dofetilide for the maintenance of normal sinus rhythm in adults with atrial fibrillation or atrial fl…
-
CLINICAL_TRIALS trial_result · 2018-09-27Clinical Trial Update: Electrical Cardioversion, Ablation or Pace and Ablate for Persistent Atrial Fibrillation [Phase 4]
Phase 4 clinical trial update evaluating electrical cardioversion, ablation, or pacing strategies for persistent atrial fibrillation has com…
-
FDA label_change · 2018-09-20FDA Approved: LANOXIN — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for LANOXIN (digoxin) submitted by Covis Pharma US, Inc. The action updates the product labeling…
-
CLINICAL_TRIALS withdrawal · 2018-09-17Clinical Trial Update: Efficacy and Safety of Rivaroxiban Compare With Vitamin K Antagonist Warfarin [Phase 4]
A Phase 4 trial comparing rivaroxiban with warfarin for mitral valve stenosis and atrial fibrillation has been withdrawn.
-
CLINICAL_TRIALS research · 2018-09-14Clinical Trial Update: Treatment Pattern of Oral Anticoagulants (OAC) in Japan
Clinical trial update describing treatment patterns of oral anticoagulants in Japan for atrial fibrillation; results completed with posted r…
-
FDA approval · 2018-08-30FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approves Upsher-Smith's generic diltiazem hydrochloride through an original ANDA (ANDA205231) for use as a calcium channel blocker.
-
FDA approval · 2018-08-24FDA Approved: DIGOXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Digoxin (DIGOXIN) from Hikma Pharmaceuticals USA Inc.
-
FDA label_change · 2018-08-24FDA Approved: LANOXIN — Supplemental Application (Covis Pharma US, Inc)
FDA approves a supplemental application for LANOXIN (digoxin) filed by Covis Pharma US, Inc., resulting in changes to the product labeling.
-
CLINICAL_TRIALS trial_result · 2018-08-22Clinical Trial Update: Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients [Phase 2]
A phase 2 trial reports on prolonging the interval between INR monitoring in stable patients on warfarin, with completion and results posted…
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Atrial Fibrillation Ablation Device Comparison Study [Phase 4]
A Phase 4 trial comparing atrial fibrillation ablation devices was withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-08-16Clinical Trial Update: Homeopathy for Prevention of Atrial Fibrillation After Aortocoronary Bypass Surgery [Phase 4]
Phase 4 trial update on homeopathy for prevention of atrial fibrillation after aortocoronary bypass surgery; study terminated.
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Influence of Sleep Apnea on Risk of Atrial Fibrillation [NA]
The study reports completed results on the relationship between sleep apnea and risk of atrial fibrillation. Findings appear to relate to di…
-
CLINICAL_TRIALS trial_result · 2018-08-14Clinical Trial Update: Misoprostol for Small Bowel Ulcers and Obscure Bleeding Due to Aspirin or Nonsteroidal Antiinflammatory Drugs [Phase 3]
Phase 3 clinical trial update on misoprostol for small bowel ulcers and obscure bleeding associated with aspirin or NSAID use has completed.